Evaluating DFPP for microplastic reduction
Part of Blood & lymphatic clinical trials.
This trial tests whether DFPP, a blood filtration treatment you may already be receiving, can reduce microplastics in your blood. If you are already scheduled for DFPP, you may help us learn more about its benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You weigh more than 88 pounds (40 kg)
- Your doctor has already prescribed DFPP (a blood filtering treatment) for you
- You have not had another blood filtering treatment (plasmapheresis) in the past 7 days
- You are willing to give blood samples before and after your DFPP session
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
This study compares two ways of filtering your blood (plasmapheresis) to see how each affects your blood's ability to clot. If you already receive regular plasmapheresis with citrate, you might help doctors learn which method is safer for you.
This study looks at whether tiny plastic particles in the blood are linked to how well the small blood vessels of the heart work and to future heart health. If you are having a heart catheterization (a test to check the heart's blood vessels), your participation could help us understand these links.
This study looks back at the medical records of people who had plasmapheresis (TPE) treatment to learn more about how it works. If you had this treatment between 2019 and 2023, researchers may use your data.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This study uses safe, painless scans (like muscle ultrasound and a body composition test) to track changes in muscle and fat in patients with IPF or PPF who are starting anti-fibrotic medication. The goal is to better understand how these treatments affect your body.
Hear when a new Microplastic and Nanoplastic Particle Burden in Peripheral Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.